Market Intelligence Report
China’s appetite for investing in and licensing US Medical Technology continues to be on the forefront of their Government’s long term plans. If you believe that your Med-Tech device has a potential market for the 1.4 billion people in China, before you invest financial and human capital we will develop an affordable market intelligence report specifically for your companies product or service. This report would include:
• Relevant general market data to understand the current market conditions and the opportunity in China
• Relevant Chinese NMPA Regulatory and legal requirements and the requisite pathway, cost and timing to understand the steps necessary to
enter into the China market while maintaining compliance
• Market entry model options to assist in making intelligent strategic decisions
• Distribution Channels to market
• Social and private insurance reimbursement
• China Hospital Data
• Green Lane Opportunities
• Relevant and specific Chinese Market intelligence and related statistical data
• Recommended next steps
Sample table of contents below. For more information please contact jun@cu-bd.com
Discovery & Assessment Phase
Discovery is an information-gathering process meant to dig deep into the details of what is important to your business expansion in China. This may include seeking a Chinese investment partner, China market access, a manufacturing partner and/or distribution partnerships. The scope and depth of research and inquiry will differ from project to project, but the results are the same: valuable data. The more information we can gather, the more prepared we will be to execute successfully which will you save time and costs.
IND Planning & Clinical Trials
Prior to the CFDA registration process, and depending upon the product classification, China regulations may require clinical data for product registration. We work directly with trusted CRO’s to manage the clinical trial process for our clients.
National Medical Products Association Process
If your product requires NMPA (China FDA) approval in China, we can assit in managing the process in conjunction with our experienced strategic partners. We provide our clients with a choice of CFDA consultancies, coordinate and liaise during the process.
Engineering and Sourcing
CUBD has worked extensively over the years with manufacturers of medical products and devices in China. Should you require simple assembly or complete design and manufacturing of your device, we will identify and screen quality manufacturers for consideration.
Distribution
CUBD has an extensive network in China with relationships in hospitals, distributors, manufacturers and medical associations to assist you in identifying the right partner to bring your product to market. We have strategic partnerships, including the China Association of Medical Devices who have more than 4,000 members, as well as key opinion leaders throughout the industry that we make available to our clients.
